Early research (Phase 1)UnknownNCT05982756
What this trial is testing
Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML
Who this might be right for
BortezomibAcute Myeloid Leukemia
Zhongnan Hospital 40
Showing 15 of 15 results